Finance Brief

Finance Brief, Industry

October 2024 review: M&A, licensing, and investments in one place

October 2024 saw notable activity in mergers, acquisitions, and strategic investments within the biotech and life sciences industries.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Microbiome Post
MicrobiomePost
Microbiomehub
MicrobiomeHUB
Follow us
Linkedin X-twitter Facebook-f
© 2016-2025 Clorofilla Scientific Publishing

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

© ALL RIGHTS RESERVED

Read MicrobiomePost’s Privacy Policy

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

Scroll to Top